Time dependent pre-treatment EPID dosimetry for standard and FFF VMAT

被引:45
作者
Podesta, Mark [1 ]
Nijsten, Sebastiaan M. J. J. G. [1 ]
Persoon, Lucas C. G. G. [1 ]
Scheib, Stefan G. [2 ]
Baltes, Christof [2 ]
Verhaegen, Frank [1 ,3 ]
机构
[1] MUMC, MAASTRO, Dept Radiat Oncol, Maastricht, Netherlands
[2] Varian Med Syst iLab GmbH, Res & Dev, Dattwil Baden, Switzerland
[3] McGill Univ, Dept Oncol, Med Phys Unit, Montreal, PQ, Canada
关键词
VMAT; time dependent; EPID dosimetry; control point; VOLUMETRIC-MODULATED ARC; RESPONSE CHARACTERISTICS; LAG CORRECTION; PORTAL IMAGES; VERIFICATION; IMRT; THERAPY; BEAM; QA; DECONVOLUTION;
D O I
10.1088/0031-9155/59/16/4749
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Methods to calibrate Megavoltage electronic portal imaging devices (EPIDs) for dosimetry have been previously documented for dynamic treatments such as intensity modulated radiotherapy (IMRT) using flattened beams and typically using integrated fields. While these methods verify the accumulated field shape and dose, the dose rate and differential fields remain unverified. The aim of this work is to provide an accurate calibration model for time dependent pre-treatment dose verification using amorphous silicon (a-Si) EPIDs in volumetric modulated arc therapy (VMAT) for both flattened and flattening filter free (FFF) beams. A general calibration model was created using a Varian TrueBeam accelerator, equipped with an aS1000 EPID, for each photon spectrum 6 MV, 10 MV, 6 MV-FFF, 10 MV-FFF. As planned VMAT treatments use control points (CPs) for optimization, measured images are separated into corresponding time intervals for direct comparison with predictions. The accuracy of the calibration model was determined for a range of treatment conditions. Measured and predicted CP dose images were compared using a time dependent gamma evaluation using criteria (3%, 3 mm, 0.5 sec). Time dependent pre-treatment dose verification is possible without an additional measurement device or phantom, using the on-board EPID. Sufficient data is present in trajectory log files and EPID frame headers to reliably synchronize and resample portal images. For the VMAT plans tested, significantly more deviation is observed when analysed in a time dependent manner for FFF and non-FFF plans than when analysed using only the integrated field. We show EPID-based pre-treatment dose verification can be performed on a CP basis for VMAT plans. This model can measure pre-treatment doses for both flattened and unflattened beams in a time dependent manner which highlights deviations that are missed in integrated field verifications.
引用
收藏
页码:4749 / 4768
页数:20
相关论文
共 30 条
  • [21] Pre-treatment verification of intensity modulated radiation therapy plans using a commercial electronic portal dosimetry system
    Roxby, Kathleen J.
    Crosbie, Jeffrey C.
    AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2010, 33 (01) : 51 - 57
  • [22] Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification with in vivo dosimetry
    Vinall, A. J.
    Williams, A. J.
    Currie, V. E.
    Van Esch, A.
    Huyskens, D.
    BRITISH JOURNAL OF RADIOLOGY, 2010, 83 (995) : 949 - 957
  • [23] Retrospective analysis of portal dosimetry pre-treatment quality assurance of hybrid IMRT breast treatment plans
    Koo, Meghan
    Darko, Johnson
    Osei, Ernest
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2021, 20 (01) : 22 - 29
  • [24] Development of patient-specific pre-treatment verification procedure for FLASH proton therapy based on time resolved film dosimetry
    Spruijt, K. H.
    Godart, J.
    Rovituso, M.
    Wang, Y.
    van der Wal, E.
    Habraken, S. J. M.
    Hoogeman, M.
    MEDICAL PHYSICS, 2025, 52 (02) : 1268 - 1280
  • [25] Pilot scale validation campaign of gel dosimetry for pre-treatment quality assurance in stereotactic radiotherapy
    Magugliani, G.
    Marranconi, M.
    Liosi, G. M.
    Locatelli, F.
    Gambirasio, A.
    Trombetta, L.
    Hertsyk, V
    Torri, V
    Galluccio, F.
    Macerata, E.
    Mossini, E.
    Santi, A.
    Mariani, M.
    Bombardieri, E.
    Vavassori, V.
    Salmoiraghi, P.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2023, 114
  • [26] Pre-treatment Predictors of Response for Assessing Outcomes to Standard Treatment in Infection with HCV Genotype 3
    Qureshi, Saleem
    Batool, Uzma
    Iqbal, Mussarat
    Burki, Umar Farooq
    Khan, Naqeeb Ullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (02): : 64 - 68
  • [27] Pre-treatment verification of intensity modulated radiation therapy plans using a commercial electronic portal dosimetry system
    Kathleen J. Roxby
    Jeffrey C. Crosbie
    Australasian Physical & Engineering Sciences in Medicine, 2010, 33 : 51 - 57
  • [28] Comparison of the 90Y-labelled glass microspheres liver radioembolisation dosimetry with the estimated dosimetry obtained from pre-treatment 99mTc-MAA SPECT images reconstructed with and without attenuation correction
    Demino, Laura
    Ferreira, Paulo
    Oliveira, Francisco P. M.
    Costa, Durval C.
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING-IMAGING AND VISUALIZATION, 2019, 7 (5-6) : 651 - 659
  • [29] Time-dependent benefits of pre-treatment with new oral P2Y12-inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction
    Pepe, Martino
    Cafaro, Alessandro
    Paradies, Valeria
    Signore, Nicola
    Addabbo, Francesco
    Bortone, Alessandro Santo
    Navarese, Eliano Pio
    Contegiacomo, Gaetano
    Forleo, Cinzia
    Bartolomucci, Francesco
    Di Cillo, Ottavio
    Bianchi, Francesco Paolo
    Zanna, Domenico
    Favale, Stefano
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (04) : 592 - 601
  • [30] Association between pre-treatment with statin and its inhibitory effect on the onset of coronary artery disease at the time of coronary computed tomography angiography: a new look at an old medication
    Miura-Takahashi, Erika
    Tashiro, Kohei
    Shiga, Yuhei
    Kawahira, Yuto
    Kato, Yuta
    Kuwano, Takashi
    Sugihara, Makoto
    Otsu, Yuki
    Kamimura, Hidetoshi
    Miura, Shin-ichiro
    HEART AND VESSELS, 2024, 39 (10) : 845 - 856